GUD issued optionsOn July 7 GUD was issued 240,000 options in MPH.v at $2.50 per share. The timing was odd in that I couldn't see any reason, nor natural timing. It may have been event driven. GUD is an advisor to MPH and participated in a prior deal with MPH, including with financing, to acquire an option in the rapidly growing pharmaceutical manufacturer Apicore. Perhaps GUD has helped MPH identify a second acquisition to leverage MPH's growing US salesforce as has been a goal. MPH's sales have doubled year-over-year due to its lead product AGGRASTAT aand it is already profitable. The company has a $37 million market cap making a transofmative acquistion potentially very rewarding to shareholders. MPH's stock is continuing to climb.